Cytosorbents Corporation (CTSO)

NASDAQ: CTSO · IEX Real-Time Price · USD

0.822

+0.122 (17.40%)

At close: Jul 2, 2024, 4:00 PM

0.842

+0.021 (2.49%)

After-hours: Jul 2, 2024, 7:45 PM EDT

Cytosorbents Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2006
Net Income	-28.51	-32.81	-24.56	-7.84	-19.27	Upgrade
Depreciation & Amortization	2.03	1.13	1.13	0.66	0.58	Upgrade
Share-Based Compensation	3.7	3.8	6.2	4.71	2.84	Upgrade
Other Operating Activities	1.12	-0.35	3.22	-3.14	-0.91	Upgrade
Operating Cash Flow	-21.66	-28.23	-14.01	-5.61	-16.76	Upgrade
Capital Expenditures	-0.54	-6.09	-3.64	-0.71	-0.7	Upgrade
Other Investing Activities	-0.4	-0.37	-0.64	-0.97	-0.82	Upgrade
Investing Cash Flow	-0.94	-6.46	-4.28	-1.68	-1.52	Upgrade
Share Issuance / Repurchase	14.47	-0.04	0.72	81.72	3.18	Upgrade
Debt Issued / Paid	0	5	0	-15.38	5	Upgrade
Other Financing Activities	-	-	-	-	-0	Upgrade
Financing Cash Flow	14.47	4.96	0.72	66.35	8.18	Upgrade
Exchange Rate Effect	-0.1	-0.26	-0.02	0.13	-0.04	Upgrade
Net Cash Flow	-8.22	-29.99	-17.6	59.19	-10.14	Upgrade
Free Cash Flow	-22.19	-34.32	-17.65	-6.32	-17.46	Upgrade
Free Cash Flow Margin	-61.06%	-98.94%	-40.88%	-15.42%	-69.97%	Upgrade
Free Cash Flow Per Share	-0.50	-0.79	-0.41	-0.16	-0.54	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).